| ‘Cancer associated fibroblasts’–more than meets the eye S Madar, I Goldstein, V Rotter Trends in molecular medicine 19 (8), 447-453, 2013 | 422 | 2013 |
| p53‐repressed miRNAs are involved with E2F in a feed‐forward loop promoting proliferation R Brosh, R Shalgi, A Liran, G Landan, K Korotayev, GH Nguyen, E Enerly, ... Molecular systems biology 4 (1), 229, 2008 | 187 | 2008 |
| Mutant p53R175H upregulates Twist1 expression and promotes epithelial–mesenchymal transition in immortalized prostate cells I Kogan-Sakin, Y Tabach, Y Buganim, A Molchadsky, H Solomon, ... Cell Death & Differentiation 18 (2), 271-281, 2011 | 182 | 2011 |
| TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model O Leshem, S Madar, I Kogan-Sakin, I Kamer, I Goldstein, R Brosh, ... PloS one 6 (7), e21650, 2011 | 154 | 2011 |
| Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species E Kalo, I Kogan-Sakin, H Solomon, E Bar-Nathan, M Shay, Y Shetzer, ... Journal of cell science 125 (22), 5578-5586, 2012 | 128 | 2012 |
| p53, a novel regulator of lipid metabolism pathways I Goldstein, O Ezra, N Rivlin, A Molchadsky, S Madar, N Goldfinger, ... Journal of hepatology 56 (3), 656-662, 2012 | 111 | 2012 |
| Modulated expression of WFDC1 during carcinogenesis and cellular senescence S Madar, R Brosh, Y Buganim, O Ezra, I Goldstein, H Solomon, I Kogan, ... Carcinogenesis 30 (1), 20-27, 2009 | 108 | 2009 |
| Various p53 mutant proteins differently regulate the Ras circuit to induce a cancer-related gene signature H Solomon, Y Buganim, I Kogan-Sakin, L Pomeraniec, Y Assia, S Madar, ... Journal of cell science 125 (13), 3144-3152, 2012 | 102 | 2012 |
| Chemotherapeutic agents induce the expression and activity of their clearing enzyme CYP3A4 by activating p53 I Goldstein, N Rivlin, O Shoshana, O Ezra, S Madar, N Goldfinger, ... Carcinogenesis 34 (1), 190-198, 2013 | 96 | 2013 |
| Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1 I Kogan-Sakin, M Cohen, N Paland, S Madar, H Solomon, A Molchadsky, ... Carcinogenesis 30 (4), 698-705, 2009 | 94 | 2009 |
| p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways Y Buganim, H Solomon, Y Rais, D Kistner, I Nachmany, M Brait, S Madar, ... Cancer research 70 (6), 2274-2284, 2010 | 92 | 2010 |
| p53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production I Goldstein, K Yizhak, S Madar, N Goldfinger, E Ruppin, V Rotter Cancer & metabolism 1, 1-6, 2013 | 87 | 2013 |
| Differential Influence of Normal and Cancer-Associated Fibroblasts on the Growth of Human Epithelial Cells in an In vitro Cocultivation Model of Prostate Cancer N Paland, I Kamer, I Kogan-Sakin, S Madar, N Goldfinger, V Rotter Molecular Cancer Research 7 (8), 1212-1223, 2009 | 87 | 2009 |
| Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect M Milyavsky, I Shats, A Cholostoy, R Brosh, Y Buganim, L Weisz, I Kogan, ... Cancer Cell 11 (2), 133-146, 2007 | 84 | 2007 |
| Mutant p53 gain of function is interwoven into the hallmarks of cancer H Solomon, S Madar, V Rotter The Journal of pathology 225 (4), 475-478, 2011 | 81 | 2011 |
| A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype Y Buganim, I Goldstein, D Lipson, M Milyavsky, S Polak-Charcon, ... PloS one 5 (3), e9657, 2010 | 79 | 2010 |
| p53 counteracts reprogramming by inhibiting mesenchymal-to-epithelial transition R Brosh, Y Assia-Alroy, A Molchadsky, C Bornstein, E Dekel, S Madar, ... Cell Death & Differentiation 20 (2), 312-320, 2013 | 64 | 2013 |
| Transcriptional activity of ATF3 in the stromal compartment of tumors promotes cancer progression Y Buganim, S Madar, Y Rais, L Pomeraniec, E Harel, H Solomon, E Kalo, ... Carcinogenesis 32 (12), 1749-1757, 2011 | 55 | 2011 |
| SPATA18, a spermatogenesis-associated gene, is a novel transcriptional target of p53 and p63 C Bornstein, R Brosh, A Molchadsky, S Madar, I Kogan-Sakin, I Goldstein, ... Molecular and cellular biology, 2011 | 55 | 2011 |
| p53‐dependent transcriptional regulation of EDA2R and its involvement in chemotherapy‐induced hair loss R Brosh, R Sarig, EB Natan, A Molchadsky, S Madar, C Bornstein, ... FEBS letters 584 (11), 2473-2477, 2010 | 51 | 2010 |
Yossi BuganimPrincipal Investigator, The Hebrew University of Jerusalem, Israel在 ekmd.huji.ac.il 的电子邮件经过验证
Yossi BuganimPrincipal Investigator, The Hebrew University of Jerusalem, Israel在 ekmd.huji.ac.il 的电子邮件经过验证
Doron LipsonCSO, Ultima Genomics在 ultimagen.com 的电子邮件经过验证